Facts & Figures for Healthcare Market in Thailand. Including information on the universal healthcare program, hospitals segment, key trends to impact hospital sector, five force analysis for private hospital, drug market value and medical device market value.
Future of Thailand's Healthcare Industry in tier 2 cities
http://www.solidiance.com/whitepaper/future-of-thailands-healthcare-industry-in-tier-2-cities.pdf
http://www.marketresearchthailand.com/thailands-tier-2-cities-strive-in-medical-tourism/
Over the past 3 years, medical device companies in Thailand performed well from both revenue and net profit perspective. Thailand is expecting to be the leader of Healthcare and medical device market in ASEAN.
Find out more about Medical device market in ASEAN, check out our paper at http://bit.ly/1hmvwFq
An introductory overview of healthcare across South East Asia and a look at the growing healthcare trends across the region.
Download the presentation by clicking the "Save this presentation" icon above.
HealthCare System in Thailand:Past -
Present and Where is the Future ?
Dr. Pradit Sintavanarong
Minister of Ministry of Public Health, Thailand
ริชมอนด์ 11-10-56
Amid a general slowdown of the global pharmaceutical market, pharmerging markets continue to be a formidable engine of growth; across Asia, Africa and South America, these markets are boasting a CAGR of 10-14%. At the outer edges of these growing economies are markets identified by IMS Health as “Frontier Markets” – the next big drivers of growth, opportunity and even innovation.
Among the Frontier Markets, Myanmar is capturing the most attention. With the completion of parliamentary elections in early November of 2015, there are positive signs that the momentum for change and market liberalization will accelerate. Indeed, Myanmar resembles the early days of some of today’s leading Asian developing markets such as Vietnam and Indonesia. However, while understanding the similarities is certainly valuable, the temptation to merely duplicate entry strategies and market assumptions should be resisted. Myanmar’s underinvested healthcare infrastructure, sizeable talent gaps, and significant regulatory and affordability hurdles, require an informed approach, and managed expectations. Multinationals will be challenged to re-evaluate what it takes to play, and what it means to win in both the short and long term.
Facts & Figures for Healthcare Market in Thailand. Including information on the universal healthcare program, hospitals segment, key trends to impact hospital sector, five force analysis for private hospital, drug market value and medical device market value.
Future of Thailand's Healthcare Industry in tier 2 cities
http://www.solidiance.com/whitepaper/future-of-thailands-healthcare-industry-in-tier-2-cities.pdf
http://www.marketresearchthailand.com/thailands-tier-2-cities-strive-in-medical-tourism/
Over the past 3 years, medical device companies in Thailand performed well from both revenue and net profit perspective. Thailand is expecting to be the leader of Healthcare and medical device market in ASEAN.
Find out more about Medical device market in ASEAN, check out our paper at http://bit.ly/1hmvwFq
An introductory overview of healthcare across South East Asia and a look at the growing healthcare trends across the region.
Download the presentation by clicking the "Save this presentation" icon above.
HealthCare System in Thailand:Past -
Present and Where is the Future ?
Dr. Pradit Sintavanarong
Minister of Ministry of Public Health, Thailand
ริชมอนด์ 11-10-56
Amid a general slowdown of the global pharmaceutical market, pharmerging markets continue to be a formidable engine of growth; across Asia, Africa and South America, these markets are boasting a CAGR of 10-14%. At the outer edges of these growing economies are markets identified by IMS Health as “Frontier Markets” – the next big drivers of growth, opportunity and even innovation.
Among the Frontier Markets, Myanmar is capturing the most attention. With the completion of parliamentary elections in early November of 2015, there are positive signs that the momentum for change and market liberalization will accelerate. Indeed, Myanmar resembles the early days of some of today’s leading Asian developing markets such as Vietnam and Indonesia. However, while understanding the similarities is certainly valuable, the temptation to merely duplicate entry strategies and market assumptions should be resisted. Myanmar’s underinvested healthcare infrastructure, sizeable talent gaps, and significant regulatory and affordability hurdles, require an informed approach, and managed expectations. Multinationals will be challenged to re-evaluate what it takes to play, and what it means to win in both the short and long term.
An introduction to Myanmar's current healthcare system with an eye on whether the country is ready for meaningful foreign direct investment in the sector.
The insights driving superior healthcare
outcomes in Asia Pacific.
Asia-Pacific Insight Magazine brings together IMS Health experts from across the region to engage in conversations about the forces that are shaping healthcare in Asia - and the strategies necessary to surge ahead of the competition
According to Pharmaion report “India Hospital Market Report”, hospital market in India is projected to reach US$ 189 billion by 2020. Growing incidences of non-communicable diseases, increasing demand for high quality healthcare, booming medical tourism and rising number of foreign investments towards establishing new hospitals is driving the country’s hospital market.
As the economy continues to grow in Myanmar, one of the areas that has seen a major overhaul is the healthcare industry. This Research Note from Ipsos Business Consulting explores the healthcare sector in Myanmar, including their healthcare systems and facilities, opportunity sectors and medical tourism.
Healthcare services ; pharmaceutical market of myanmarAccord Healthcare
This report consolidates the main developments of the pharmaceutical market in Myanmar over the last decade. Among the APAC Markets, Myanmar is catching the most attention after the Vietnam. The report provides in-depth information on the healthcare medical system & Pharmaceutical market of Myanmar.
The Indian healthcare industry has progressed at an impressive pace over the past few years. The private sector has emerged as a vibrant force in the industry, accounting for almost 74 per cent of the country’s total healthcare expenditure.
The Indian healthcare revenues stood at US$ 68.4 billion in 2011 and is expected to reach US$ 158.2 billion by 2017. Of the total healthcare revenues in the country, hospitals account for 71 per cent, pharmaceuticals for 13 per cent and medical equipment and supplies for 9 per cent.
India offers both a huge patient pool, favourable regulatory environment and cost advantage for conducting clinical trials. The low cost of medical services has resulted in a rise in the country’s medical tourism, attracting patients from across the world.
The Government of India has created the National Health Mission (NHM) for providing effective healthcare to both urban and rural population.
The insights driving superior healthcare outcomes in Asia Pacific.
Asia-Pacific Insight Magazine brings together IMS Health experts from across the region, delivering fresh perspectives on how to navigate through the challenges and opportunities in Asia-Pacific pharmaceutical market.
Vibrant Gujarat Summit Profile on Healthcare Sector investmentVibrant Gujarat
To be the network of finest public healthcare institutions in the state of Gujarat, providing quality medical care services with the state of the art technology with easy accessibility, affordability & equity to the people of Gujarat & beyond.
Medical services are meant for curative care via diagnosis and treatment. Medical Relief services mainly are centred in the urban areas of the state and are delivered through the following hospitals, which are the leading hospitals at the district and State Infrastructure hospitals, the sub‐district level for all the districts.
IBC’s Indonesia Healthcare conference brings together healthcare leaders to discuss evolving policies, opportunities for private healthcare investment, partnerships, projects and initiatives.
Key Conference Themes:
Updates on Regulation and the Road Towards Universal Healthcare Coverage
Hospital Management & Cutting Edge Healthcare Delivery Standards
Digital Marketing and Telehealth Solutions
Healthcare Infrastructure Projects, Investments & Development
Generics & Access to Medicine
Public-Private Partnerships & Collaboration
Why You Must Attend This Year’s Event
Understand the proactive steps to take by hospitals, pharmaceutical and insurance companies for the new Universal Healthcare Coverage policy
Discover partnerships and investment opportunities in Indonesia
Hear different case studies from major hospitals, insurance and pharmaceutical companies
Meet and exchange business cards with your peers during the networking sessions
Learn how to deliver safe and quality healthcare from other Asian countries
With Thai consumers paying more attention to their health, many investors are focused on the Healthcare market in Thailand as part of their growth plans in the Asia Pacific.
Contact our healthcare team to find out more. Email: healthcare.bc@ipsos.com
An introduction to Myanmar's current healthcare system with an eye on whether the country is ready for meaningful foreign direct investment in the sector.
The insights driving superior healthcare
outcomes in Asia Pacific.
Asia-Pacific Insight Magazine brings together IMS Health experts from across the region to engage in conversations about the forces that are shaping healthcare in Asia - and the strategies necessary to surge ahead of the competition
According to Pharmaion report “India Hospital Market Report”, hospital market in India is projected to reach US$ 189 billion by 2020. Growing incidences of non-communicable diseases, increasing demand for high quality healthcare, booming medical tourism and rising number of foreign investments towards establishing new hospitals is driving the country’s hospital market.
As the economy continues to grow in Myanmar, one of the areas that has seen a major overhaul is the healthcare industry. This Research Note from Ipsos Business Consulting explores the healthcare sector in Myanmar, including their healthcare systems and facilities, opportunity sectors and medical tourism.
Healthcare services ; pharmaceutical market of myanmarAccord Healthcare
This report consolidates the main developments of the pharmaceutical market in Myanmar over the last decade. Among the APAC Markets, Myanmar is catching the most attention after the Vietnam. The report provides in-depth information on the healthcare medical system & Pharmaceutical market of Myanmar.
The Indian healthcare industry has progressed at an impressive pace over the past few years. The private sector has emerged as a vibrant force in the industry, accounting for almost 74 per cent of the country’s total healthcare expenditure.
The Indian healthcare revenues stood at US$ 68.4 billion in 2011 and is expected to reach US$ 158.2 billion by 2017. Of the total healthcare revenues in the country, hospitals account for 71 per cent, pharmaceuticals for 13 per cent and medical equipment and supplies for 9 per cent.
India offers both a huge patient pool, favourable regulatory environment and cost advantage for conducting clinical trials. The low cost of medical services has resulted in a rise in the country’s medical tourism, attracting patients from across the world.
The Government of India has created the National Health Mission (NHM) for providing effective healthcare to both urban and rural population.
The insights driving superior healthcare outcomes in Asia Pacific.
Asia-Pacific Insight Magazine brings together IMS Health experts from across the region, delivering fresh perspectives on how to navigate through the challenges and opportunities in Asia-Pacific pharmaceutical market.
Vibrant Gujarat Summit Profile on Healthcare Sector investmentVibrant Gujarat
To be the network of finest public healthcare institutions in the state of Gujarat, providing quality medical care services with the state of the art technology with easy accessibility, affordability & equity to the people of Gujarat & beyond.
Medical services are meant for curative care via diagnosis and treatment. Medical Relief services mainly are centred in the urban areas of the state and are delivered through the following hospitals, which are the leading hospitals at the district and State Infrastructure hospitals, the sub‐district level for all the districts.
IBC’s Indonesia Healthcare conference brings together healthcare leaders to discuss evolving policies, opportunities for private healthcare investment, partnerships, projects and initiatives.
Key Conference Themes:
Updates on Regulation and the Road Towards Universal Healthcare Coverage
Hospital Management & Cutting Edge Healthcare Delivery Standards
Digital Marketing and Telehealth Solutions
Healthcare Infrastructure Projects, Investments & Development
Generics & Access to Medicine
Public-Private Partnerships & Collaboration
Why You Must Attend This Year’s Event
Understand the proactive steps to take by hospitals, pharmaceutical and insurance companies for the new Universal Healthcare Coverage policy
Discover partnerships and investment opportunities in Indonesia
Hear different case studies from major hospitals, insurance and pharmaceutical companies
Meet and exchange business cards with your peers during the networking sessions
Learn how to deliver safe and quality healthcare from other Asian countries
With Thai consumers paying more attention to their health, many investors are focused on the Healthcare market in Thailand as part of their growth plans in the Asia Pacific.
Contact our healthcare team to find out more. Email: healthcare.bc@ipsos.com
Understand more about the Awareness, Affordability and Access strategic framework to drive success for global pharma companies engaging with Asian Markets.
Presentation file on "Thailand: An ASEAN Hub, A World of Opportunities" by Ms. Ajarin Pattanapanchai, Senior Executive Investment Advisor, Thailand Board of Investment, June 15, 2015 at Courtyard Philadelphia Downtown (BIO 2015)
Thailand's medical devices sector is one of the most well-known and well-established sectors in ASEAN countries. To better illustrate, the trade value for this industry is 19.93 billion US dollars.
Abstract: Medical tourism is a growing phenomenon with policy implications for health systems, particularly of destination countries. Private actors and governments in Southeast Asia are promoting the medical tourist industry. This article presents a conceptual framework that outlines the policy implications of medical tourism's growth for health systems, drawing on the cases of Thailand, Singapore and Malaysia and other hubs for medical tourism. Variables for further analysis of the potential impact of medical tourism on health systems are also identified. The framework can provide a basis for empirical, in country studies weighing the benefits and disadvantages of medical tourism for health systems. The policy implications described are of particular relevance for policymakers and industry practitioners in other Southeast Asian countries with similar health systems where governments have expressed interest in facilitating the growth of the medical tourist industry. This article calls for a universal definition of medical tourism and medical tourists to be enunciated, as well as concerted data collection efforts, to be undertaken prior to any meaningful empirical analysis of medical tourism's impact on health systems.
Motivation and Decision on Medical Tourism Service in Thailand Nattie Bua
This research involves discovering what are the motivations and factors that influence customers on making decision for medical tourism service in the case of Thailand.
On Wednesday, March 9th, 2022, ProColombia, APC-Colombia, and the Thai Ministry of Public Health carried out a webinar alongside collaborators from the Colombian Ministry of Health & Social Protection, the National Association of Industries (ANDI), and high-level hospitals from Colombia with the aim of sharing knowledge and policies regarding medical service tourism.
India Medical Devices Market: Industry Size and Growth Trends [2029] Analyzed...Kumar Satyam
According to TechSci Research report, "India Medical Devices Market Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2019-2029," the India medical devices market was valued at USD 15.35 billion in 2023 and is anticipated to witness impressive growth over the forecast period with a Compound Annual Growth Rate (CAGR) of 5.35% through 2029. This growth can be attributed to several factors, including collaborations and partnerships among leading companies, government initiatives, and the growing population. The market is segmented based on type, end-user, and region.
Population Growth
The growing population is a significant driver for the demand for medical devices. As the population increases, there is a higher demand for healthcare services, which in turn drives the need for diagnostic, therapeutic, and monitoring devices. A larger population leads to a greater emphasis on preventive healthcare and early disease detection, thereby increasing the demand for diagnostic devices and screening equipment.
Aging Population
An expanding population often includes a larger aging demographic, which tends to have more healthcare needs. This demographic shift drives the demand for medical devices like monitoring equipment, mobility aids, and drug delivery systems. The aging population also requires chronic disease management, further boosting the demand for specialized medical devices.
Government Initiatives
The Government of India has undertaken several initiatives to strengthen the medical devices sector. The Production Linked Incentive (PLI) Scheme for medical devices aims to boost domestic manufacturing and reduce import dependency. As of now, a total of 26 projects have been approved under this scheme, with a committed investment of Rs. 1206 crore. The National Medical Devices Policy, 2023, is expected to facilitate the orderly growth of the sector, focusing on access, affordability, quality, and innovation.
Technological Advancements
Rapid advancements in medical technology necessitate constant upgrades and the introduction of new devices. The development of innovative medical devices requires significant investment in research and development (R&D). While India has made strides in R&D, it still lags in the development of high-end medical technologies, leading to a dependence on imports for the latest devices.
Following North America and EU, Southeast and East Asia is ranked 3rd the highest projected pharmaceutical sales in 2024 with the value of USD 232 billion. As part of the region, Thailand’s pharmaceutical industry has grown and has been considered one of the top biopharma clusters regarding its public R&D spending, number of patents, initial public offerings, number of companies, and jobs.
medical tourism is about the person travel abroad to find the better treatment which is that country have the latest technology in medical and specialist.
Setting Up a Multispeciality Hospital Business. Investment Opportunity in Hea...Ajjay Kumar Gupta
Setting Up a Multispeciality Hospital Business. Investment Opportunity in Healthcare Sector. Multispeciality Hospital Business Plan
Humanity is protected by a medical centre or hospital. Aside from that, profit is more critical because it is also a corporation. One of the most important aspects is revenue management, as running a hospital requires a lot of luck. Various hospitals and health care facilities can be found all over us. With the growing number of cases of various illnesses, it is becoming increasingly difficult and unsustainable to keep moving to different locations for different treatments. Many new diseases have arisen as a result of our sedentary lifestyle, and they require multi-specialists to treat.
For More Details:- https://www.entrepreneurindia.co/project-and-profile-details/MULTISPECIALTY%20HOSPITAL
Contact us
Niir Project Consultancy Services
An ISO 9001:2015 Company
106-E, Kamla Nagar, Opp. Mall ST,
New Delhi-110007, India.
Email: npcs.ei@gmail.com , info@entrepreneurindia.co
Tel: +91-11-23843955, 23845654, 23845886
Mobile: +91-9097075054, 8800733955
Website: www.entrepreneurindia.co , www.niir.org
The Guide to the Board of Investment was prepared by the Office of the Board of Investment to provide information regarding investment promotion, including benefits and privileges, list of eligible activities, related announcements and, also, investment promotion application’s criteria and conditions.
The guide provides an overview of the business environment in Thailand, with information about company establishment, taxation, intellectual property rights, and legal issues.
Presented by Asst. Prof. Nayot Kurukitkoson, PhD, Executive Committee of the EEC Human Development Center, and Vice President for EEC Affairs, Burapha University, on March 16, 2023
Thailand has an extensive innovation network made up of various supporting parties, from government bodies, the private sector, to venture capital and other organizations including research laboratories and academic institutions.
Thailand is the perfect second home for expats. The country was ranked 14th out of 59 global locations with the nation’s capital Bangkok placing 4th in Asia in the Expat City Ranking 2021,5 with the majority of expats expressing satisfaction with the cost of living and their quality of life in Thailand.
The Guide to the Board of Investment was prepared by the Office of the Board of Investment to provide information regarding investment promotion, including benefits and privileges, list of eligible activities, related announcements and, also, investment promotion application’s criteria and conditions.
Thailand is introducing a new visa called “Long-Term Resident (LTR )” which is a program that provides a range of tax and non-tax benefits to enhance the country’s attractiveness as a regional hub for living and doing business for high potential foreigners.
Presented by Mr. Varghese Poulouse Nalian, President & General Manager of Performance Additives Business, Momentive Performance Materials (Thailand), on June 29, 2022
This measure is aimed to promote investment in targeted activities in three provinces – Chachoengsao, Chon Buri, and Rayong, as well as to encourage private sector to participate in human resource development. As EEC development is part of the policy to drive Thailand towards Thailand 4.0, investors in the targeted activities located in designated areas or in promoted industrial estates/industrial zones, or the investors involved in the human resource development in the EEC will enjoy additional tax incentives, apart from a standard tax package.
Thailand is introducing a new visa under "Long-Term Resident (LTR)" program, which provides a wide range of tax and non-tax benefits to enhance the country's attractiveness as a regional hub for living and doing business for "high-potential" foreigners.
More from Thailand Board of Investment North America (20)
Safalta Digital marketing institute in Noida, provide complete applications that encompass a huge range of virtual advertising and marketing additives, which includes search engine optimization, virtual communication advertising, pay-per-click on marketing, content material advertising, internet analytics, and greater. These university courses are designed for students who possess a comprehensive understanding of virtual marketing strategies and attributes.Safalta Digital Marketing Institute in Noida is a first choice for young individuals or students who are looking to start their careers in the field of digital advertising. The institute gives specialized courses designed and certification.
for beginners, providing thorough training in areas such as SEO, digital communication marketing, and PPC training in Noida. After finishing the program, students receive the certifications recognised by top different universitie, setting a strong foundation for a successful career in digital marketing.
2024.06.01 Introducing a competency framework for languag learning materials ...Sandy Millin
http://sandymillin.wordpress.com/iateflwebinar2024
Published classroom materials form the basis of syllabuses, drive teacher professional development, and have a potentially huge influence on learners, teachers and education systems. All teachers also create their own materials, whether a few sentences on a blackboard, a highly-structured fully-realised online course, or anything in between. Despite this, the knowledge and skills needed to create effective language learning materials are rarely part of teacher training, and are mostly learnt by trial and error.
Knowledge and skills frameworks, generally called competency frameworks, for ELT teachers, trainers and managers have existed for a few years now. However, until I created one for my MA dissertation, there wasn’t one drawing together what we need to know and do to be able to effectively produce language learning materials.
This webinar will introduce you to my framework, highlighting the key competencies I identified from my research. It will also show how anybody involved in language teaching (any language, not just English!), teacher training, managing schools or developing language learning materials can benefit from using the framework.
Introduction to AI for Nonprofits with Tapp NetworkTechSoup
Dive into the world of AI! Experts Jon Hill and Tareq Monaur will guide you through AI's role in enhancing nonprofit websites and basic marketing strategies, making it easy to understand and apply.
Macroeconomics- Movie Location
This will be used as part of your Personal Professional Portfolio once graded.
Objective:
Prepare a presentation or a paper using research, basic comparative analysis, data organization and application of economic information. You will make an informed assessment of an economic climate outside of the United States to accomplish an entertainment industry objective.
Francesca Gottschalk - How can education support child empowerment.pptxEduSkills OECD
Francesca Gottschalk from the OECD’s Centre for Educational Research and Innovation presents at the Ask an Expert Webinar: How can education support child empowerment?
Operation “Blue Star” is the only event in the history of Independent India where the state went into war with its own people. Even after about 40 years it is not clear if it was culmination of states anger over people of the region, a political game of power or start of dictatorial chapter in the democratic setup.
The people of Punjab felt alienated from main stream due to denial of their just demands during a long democratic struggle since independence. As it happen all over the word, it led to militant struggle with great loss of lives of military, police and civilian personnel. Killing of Indira Gandhi and massacre of innocent Sikhs in Delhi and other India cities was also associated with this movement.
Embracing GenAI - A Strategic ImperativePeter Windle
Artificial Intelligence (AI) technologies such as Generative AI, Image Generators and Large Language Models have had a dramatic impact on teaching, learning and assessment over the past 18 months. The most immediate threat AI posed was to Academic Integrity with Higher Education Institutes (HEIs) focusing their efforts on combating the use of GenAI in assessment. Guidelines were developed for staff and students, policies put in place too. Innovative educators have forged paths in the use of Generative AI for teaching, learning and assessments leading to pockets of transformation springing up across HEIs, often with little or no top-down guidance, support or direction.
This Gasta posits a strategic approach to integrating AI into HEIs to prepare staff, students and the curriculum for an evolving world and workplace. We will highlight the advantages of working with these technologies beyond the realm of teaching, learning and assessment by considering prompt engineering skills, industry impact, curriculum changes, and the need for staff upskilling. In contrast, not engaging strategically with Generative AI poses risks, including falling behind peers, missed opportunities and failing to ensure our graduates remain employable. The rapid evolution of AI technologies necessitates a proactive and strategic approach if we are to remain relevant.
Read| The latest issue of The Challenger is here! We are thrilled to announce that our school paper has qualified for the NATIONAL SCHOOLS PRESS CONFERENCE (NSPC) 2024. Thank you for your unwavering support and trust. Dive into the stories that made us stand out!
2. THAILAND:
MEDICAL HUB
OF ASIA
Thailand is well positioned to be the medical hub
of Asia. The country offers state-of-the-art facilities
and technologies, internationally certified medical
services, excellent medical expertise, highly qualified
medical professionals, and a wide range of high-
standard hospitals. Thailand also has a significant
number of internationally accredited medical
facilities.
In order to develop Thailand into an “International
Health Center for Excellence”, the Ministry of Public
Health, the national focal point for implementation
of the Medical Hub Policy, is executing its second
strategic plan (2012-2016). The plan encompasses
four major areas: medical services, integrative
wellness centers, development of Thai herbs, and
traditional and alternative Thai medicines.
Thailand is one of the world’s largest medical
tourism markets, with the number of international
patients continuing to rise. According to Thailand’s
Ministry of Public Health and the Kasikorn Research
Center, Thailand welcomed more than 2.5 million
international patients in 2012, a 13% increase from
2011. Thailand’s 2012 revenue from medical tourism
was between US$4.0 billion and US$4.7 billion, up
from US$3.2 billion in 2011.
3. Top 10 Medical Tourism Destinations
Brazil Costa Rica
Hungary India
Malaysia Mexico
Singapore South Korea
Thailand Turkey
Source: Positivemed, as of March 2013
Thailand also attracts thousands of international
patients with its traditional and alternative
medicines. Alternative medicine uses herbal
medicines, biofeedback, and acupuncture in
lieu of drugs. A broad range of practices are used
including homeopathy, naturopathy, chiropractic,
and acupuncture. The Thailand Ministry of Public
Health has formally supported the field in an effort to
promoteThai traditional and alternative medicines in
hospitals nationwide.
The initiatives that Thailand has undertaken to
strengthen its position as the medical hub of Asia
have created opportunities for continued growth
in related fields, including the medical services,
medical device, and pharmaceutical sectors. As a
result, Thailand has become an excellent location for
investment.
4. FIRST-CLASS
QUALITY AT
AFFORDABLE
PRICES
Thailand emerged as a leading medical tourism
destination because of its robust medical services
sector. Millions of medical tourists from all over the
world are drawn to the country by its high-quality,
internationally certified medical services, cutting-
edge medical equipment, experienced physicians,
and affordable prices.
Thailand offers world-class medical facilities. Thai
hospitals are among the first in Asia to be Joint
Commission International (JCI) accredited. Over
1,000 public and 400 private hospitals across the
country operate in compliance with international
standards and employ internationally trained
physicians. Thailand provides excellent healthcare
services at highly competitive prices.
Thaihospitalsalsoofferadvancedmedicalequipment
such as Picture Archiving and Communication
Systems (PACS). These systems provide a wide range
of imaging services, including radiotherapy, CT and
MRI scans, angiography, cardiology, fluoroscopy,
5. ultrasounds, dental imaging, and mammography.
The images are stored in the hospital’s network, and
doctors can access the data anywhere in the hospital.
Additionally, the Cyber Knife Robotic Radiosurgery
System is an alternative treatment for tumors. The
Cyber Knife treatment involves delivering beams of
high dose radiation to tumors with extreme accuracy
while also being pain-free.
International patients visit Thailand for a variety of
treatments including general check-ups, dentistry,
cancer treatments, hip replacements, kidney
transplants, cardiology testing, heart surgeries,
laser eye surgeries, cosmetic surgeries, weight loss
surgeries, and sex change operations. The price of
surgery services inThailand is far lower than the price
of similar procedures in the USA or Europe. Thailand
also narrowly edges out Singapore in surgery
price comparisons, contributing to the country’s
domination in the global medical tourism market.
In addition to Thailand’s competitive pricing, the
country’s high standards and quality care contribute
to its market success. Thai private hospitals rank
among the highest in healthcare and nursing
standards. With warm hospitality, patients feel right
at home. Many hospitals have specialized English
speaking staff and several provide translators in a
wide variety of foreign languages, including Arabic,
Japanese and Chinese.
An array of treatment options, affordable costs, and
high service standards make Thailand an excellent
destination for medical tourists. The Thai medical
industry has strong growth potential and continues
to benefit from the government’s support in
developing medical services and facilities.
6. MEDICAL DEVICES
The Thai government’s continued efforts to develop the country into an Asian medical
hub have driven demand of medical services and devices. Although a wide range
of medical devices are manufactured domestically, Thailand still relies heavily on
imported medical devices, especially sophisticated and higher-end devices. This
backdrop creates an opportunity for new investment in high-end medical device
manufacturing in Thailand.
Increased demand in the healthcare market is a key driver of the Thai medical device
industry. As Thailand’s universal healthcare system continues to develop, demand for
medical devices and services is likely to increase as well.
Thailand Market for Medical Devices, 2011-2014f
Source: Country Commercial Guide for U.S. Companies, as of October 2013
As illustrated in the chart above, the market for medical devices has strongly grown. In
2012, the market for medical devices inThailand was US$2 billion, a 24% increase from
the previous year. The market is predicted to reach US$2.5 billion and US$3 billion in
2013 and 2014, respectively.
Thailand’s Imports and Exports of
Major Medical Devices/Disposable, 2013 (Jan-Aug)
Description
Import
(million
US$)
Export
(million
US$)
HS9018: Instruments and appliances used in medical,
surgical, dental or veterinary sciences
341.43 311.22
HS900150: Spectacle lenses of other materials 177.85 583.03
HS9022: Apparatus based on the use of X-rays or of alpha,
beta or gamma radiations, whether or not for medical,
surgical, dental or veterinary uses
146.85 9.52
0
500
1,000
1,500
2,000
2,500
3,000
3,500
2011 2012 2013 2014 f
3,103
2,497
2,011
1,617
MillionUS$
7. Description
Import
(million
US$)
Export
(million
US$)
HS3822: Diagnostic or laboratory reagents on a backing,
prepared diagnostic or laboratory regents whether or not
on a backing, other than those of heading 30.02 or 30.06:
certified reference materials
132.38 2.06
HS9030: Oscilloscopes, spectrum analyzers and other
instruments and apparatus for measuring or checking
electrical quantities, excluding meters of 9028; instruments
and apparatus for measuring or detecting alpha, beta,
gamma, X-ray, cosmic or other ionizing radiations
98.66 60.09
Source: Thailand Ministry of Commerce
Between January and August of
2013, instruments and appliances
used in medical, surgical, dental,
or veterinary sciences had the
industry’s highest imported value at
US$341 million, a 4% year-on-year
increase. Spectacle lenses of other
materials performed best with an
imported value of US$178 million,
a 38% year-on-year increase.
Illustrated in the chart below, the
largest export destinations of the
Thai medical device sector were
Japan (34%) and the US (15%).
Major international medical device
manufacturers and distributors in
Thailand include: Essilor, 3M, Bausch
& Lomb, Baxter Healthcare, Boston Scientific, Carl Zeiss, Diethelm, GE Medical Systems,
Guidant, Johnson & Johnson, Medtronic, Philips Electronics (Medical Systems), Roche
Diagnostics, Siemens (Medical Solutions) Surgical Instruments and Tyco Healthcare.
Many leading medical device companies invest in Thailand because of the country’s
high market growth potential, abundance of raw materials (especially natural rubber
as Thailand is the world’s largest producer), skilled and affordable labor, excellent
infrastructure, advanced production technology, and high quality-control standards.
Additionally, the government offers attractive investment incentives for investment in
the medical device sector.
Export of Medical Tools and Devices,
2013 (Jan-Aug)
Source: Thailand Ministry of Commerce
Others
36%
Singapore
4%
France
5% Germany
6%
U.S.A.
15%
Japan
34%
8. “The Royal Thai government has placed a greater
emphasis on the medical devices sector. Recently, the Royal
Thai government announced a strategic plan to promote
investment, research and development for medical devices
in order to increase local production and reduce reliance
on imports.
TheThaimedicaldevicesectorhasseenrobustandconsistent
growth owing to national health insurance schemes, a
medical tourism policy and the strategic government plan
to develop Thailand as a Medical Hub of ASEAN. These
factors create great opportunities for investment, R&D and
the expansion of medical device production in Thailand.”
- Mr. Preecha Bhandtivej,
President of Thai Medical Device Technology Industry Association -
PHARMACEUTICALS
According to Pacific Bridge Medical, the Thai pharmaceutical market, valued at US$4
billion in 2012, is the largest in Southeast Asia. By 2020, this value is expected to
increase to US$9 billion.
As Thailand has developed into the medical hub of Asia, its pharmaceutical market
has also experienced significant growth. Thailand’s cost-effective and high-quality
manufacturing has been a key driver in attracting foreign pharmaceutical companies.
In recent years, the increasing number of medical tourists, an aging population,
and high levels of health awareness among the Thai population have boosted
the country’s pharmaceutical image. Thailand also currently produces 25 active
pharmaceutical ingredients, including sodium chloride, camphor, and menthol. Most
active ingredients are imported from manufacturers overseas, leaving sizable room for
new pharmaceutical investors.
To ensure that pharmaceutical products in the country meet world-class standards,
the government requires that all manufacturing companies develop standards and
quality-control systems that meet Good Manufacturing Practice (GMP) standards
based on the International Pharmaceutical Inspection Cooperation Scheme (PIC/S).
The Thai pharmaceutical market is dominated by foreign manufacturers and
distributors. Leading multinational companies in Thailand include Meji, Baxter, Mega
Lifesciences, Linaria, Otsuka, Sanofi, Pfizer, Merck, Novartis and GlaxoSmithKline.
9. Thailand’s Imports and Exports of Pharmaceuticals,
2009-2013 (Jan-Aug)
Source: Thailand Ministry of Commerce
As illustrated in the chart above, Thai imports have grown steadily while exports
have only increased slightly. From January to August 2013, imports were valued at
approximately US$1.3 billion while exports were valued at US$301 million.
0
500
1,000
1,500
2,000
2009 2010 2011 2012 2013
(Jan-Aug)
301
409349333
269
1,290
1,870
1,685
1,539
1,343
Import
MillionUS$
Export
10. Thailand’s Imports and Exports of Pharmaceuticals by Countries,
2013 (Jan-Aug)
Source: Thailand Ministry of Commerce
As shown in the chart above, Thailand imports its pharmaceuticals from a variety
of pharmaceutical leaders. From January to August 2013, the US was the largest
importer of pharmaceuticals to Thailand and accounted for 13% of total imports.
Switzerland, Germany, and France were the next largest importers at 10%,
10%, and 9%, respectively. Half of the
country’s pharmaceutical exports
were destined for the ASEAN region
including Myanmar (16%), Vietnam
(15%), and Cambodia (8%).
Thailand·s Import of Pharmaceuticals 2013 (Jan-Aug)
Others
43%
India
5%
Italy
5%
UK
5%
France
9%
Germany
10%
Switzerland
10%
The US
13%
Thailand·s Export of Pharmaceuticals 2013 (Jan-Aug)
Others
37%
Malaysia
5%
Hong Kong
6%
phillippines
6%
Belgium
7%
Cambodia
8%
Vietnam
15%
Myanmar
16%
MEDICAL
FOOD
11. Medical food refers to food that is formulated to be consumed or administered under
the supervision of a physician. It is part of a specific dietary regime intended to treat a
disease or condition, and the food has distinctive nutritional requirements.
Medical food differs from regular food in that it has substantial health-promoting
or disease-preventing benefits beyond the basic delivery of nutrients. It differs from
nutritional supplements in that it is not designed for use by healthy persons, but
rather as a therapy for a particular medical condition under the guidance of a medical
practitioner. At minimum, medical food products must be:
• Food for oral ingestion or tube feeding (Nasogastric tube);
• Labeled for the dietary management of a specific medical disorder, disease or
condition for which there are distinctive nutritional requirements; and,
• Intended to be used under medical supervision.
Thailand’s Import and Export of Medical foods, 2013 (Jan-Aug)
Description Import
(US$)
Export
(US$)
HS19011030001: Food preparations of others - for
infants allergic to milk or for Lactase deficient infants,
not put up for retail sale
805,185 2,461,287
HS 19019090001: Food preparations of soybean powder
- for infants allergic to milk or for Lactase deficient
infants, put up for retail sale
693,677 1,792,554
HS 21069070001: Food preparations - for supplements
for seriously ill patients
2,791,040 523,640
HS 21069093000: Other food preparations - for Lactase
deficient infants
13,181,443 298,149
HS 19011091000: Medical Foods 1,566,864 3,031
Source: Thailand Ministry of Commerce
Thailand’s medical food market is experiencing strong growth and has benefited from
the country’s medical services sector. Many leading medical food producers invest
in Thailand because of the country’s agricultural raw materials, skilled, affordable
labor, advanced technology, and high quality-control standards. Additionally, the
government offers attractive incentives to investors in this sector. As a result, Thailand
is an excellent strategic location for the manufacturing of medical food.
Major suppliers of medical food are establishing facilities in Thailand, including Mead
Johnson Nutrition, Abbott, Novartis and Thai Otsuka Pharmaceutical. Mead Johnson
Nutrition Thailand is the company’s largest manufacturing plant outside of the US and
serves as its hub for Asia Pacific operations.
12. QUALITY AND SAFETY OF
SERVICES
Thailand has a significant number of internationally accredited hospitals. Thailand
was the first country in Asia to acquire Joint Commission International Accreditation
(JCIA), the international accreditation of the US Joint Commission on Accreditation of
Healthcare Organizations (JCAHO). Thailand provides overseas trained doctors that
operate at international standards at extremely competitive costs. Moreover, many
private hospitals employ a specialized English-speaking staff as well as staff trained in
a wide variety of foreign languages.
Thailand’s 26 JCI Accredited Hospitals
Bangkok Hospital Hua Hin Chaophaya Hospital Samitivej Hospital
Srinakarin
Bangkok Hospital Medical
Center
Chiangmai Ram Hospital Samitivej Hospital
Sriracha
Bangkok Hospital Pattaya Navamin 9 Hospital Samitivej Hospital
Sukhumvit
Bangkok Hospital Phuket Nonthavej Hospital Sikarin Hospital
Bangkok Hospital Samui Phuket International
Hospital
Synphaet Hospital
Bangpakok 9 International
Hospital
Pisanuvej Hospital Vejthani Hospital
BNH Hospital Praram 9 Hospital Vibbhavadi Hospital
Bumrungrad Hospital Ramkhamhaeng Hospital Yanhee Hospital
Central General Hospital Saimai Hospital
Source: Joint Commission International as of December 2013
A number of Thailand’s private hospitals have partnerships with top international
medical schools and healthcare institutions worldwide. Thai hospitals have also
achieved international standards of Hospital Accreditation (HACC) such as ISO 9002,
ISO900: 2000, ISO 14001, ISO 18000 and JCIA.
Thailand’s Food and Drug Administration (FDA) is in charge of:
• Pre-marketing control
• Post-marketing control
• Surveillance programs for consumer safety
• Consumer education
• Technical support and cooperation with other agencies
The FDA oversees the importation of three classifications of medical devices, which
can be found at the organization’s website.
13. ³7KH ¿UVW MRLQW YHQWXUH XQGHUWDNHQ E -DSDQ 2WVXND *URXS
was in Thailand and we have operated this company
VXFFHVVIXOO IRU RYHU WKH SDVW HDUV :H DUH FRQ¿GHQW
that Thailand’s strong infrastructure, competitive labor
costs and commercially sound government policy will
support and strengthen our Thai operations’growth in both
pharmaceutical and food products.”
- Mr. Motoyuki Sakiyama, President of Thai Otsuka Pharmaceutical Co., Ltd -
INTELLECTUAL
PROPERTY RIGHTS
Thailand’s 7 laws pertaining to intellectual property all meet international standards:
1) Copyrights Act of 1994
2) Patent Act of 1979, as amended by the Patent Act (No. 3) of 1999
3) Traditional Medicine and Practice Act of 1999
4) Trademark Act of 1991, as amended by the Trademark Act (No. 2) of 2000
5) Act for the Protection of Layout-Designs of Integrated Circuits 2000
6) Trade Secret Act of 2002
7) Protection of Geographical Indication Act of 2003
EXCELLENT
INFRASTRUCTURE
Thailand is home to many institutions and research centers that support the
development of medical technological breakthroughs, including;
• Thailand’s Science Park, established as a one-stop service center to assist companies
engaged in scientific and technological research
• The National Center for Genetic Engineering and Biotechnology (BIOTEC)
• National Science and Technology Development Agency (NSTDA)
• Food and Drug Administration (FDA)
• Ministry of Public Health (MOPH)
• Ministry of Science and Technology (MOST)
• National Innovation Agency (NIA)
• Health Systems Research Institute (HSRI)
• Thailand Center of Excellence for Life Sciences (TCELS)
14. WONDERFUL INVESTMENT
OPPORTUNITY AND
ENVIRONMENT
Thailand offers a number of investment advantages for foreign investors. Thailand’s
economy is one of the fastest growing economies in Asia. With a
strong business climate, Thailand was ranked 18th in the world and
3rd in Southeast Asia in terms of ease of doing business by the World
Bank’s 2014 Doing Business report. The country’s experienced and
qualified physicians can support a high-quality medical services
sector. Thailand also provides world-class infrastructure and
advanced technological equipment. These factors contribute
to the steady growth of Thailand’s healthcare services, medical
device, and pharmaceutical markets.
BOI
INVESTMENT
INCENTIVES
Thailand Board of Investment offers attractive
investment incentives to a wide range of
activities related to the medical sector such as
manufacture of medical food, manufacture of
medical equipment. Major incentives include
corporate income tax exemption, and duty
concessions on machinery and raw materials.
In addition, a number of non-tax incentives are
availablesuchasrighttoownlandandfacilitation
as regards visas and work permits for expatriates.
The BOI also promotes retirement homes and
care centers as well as dedicated health
centers, which are facilities that can
provide the processes of medical
or psychotherapeutic treatment
through the use of advanced
technological devices and facilities.
These dedicated health centers will
15. serve only the patients who need further treatment to rehabilitate, so it helps them
prevent injury and disease, recover function and strength, reduce pain and ultimately
helps them return to a more independent and productive lifestyle.
Projects in retirement homes and care centers, as well as dedicated health centers are
eligible for exemption or reduction of import duty on machinery, based on project
location, provided they achieve standards set by relevant government agencies.
OTHER GOVERNMENT
SUPPORT MEASURES
Apart from BOI incentives, several types of support are provided by other government
agencies and organizations, which include:
The Revenue Department
• 40% deduction on depreciation of machinery
• 200% deduction on training expenses
• National Science and Technology Development Agency (NSTDA)
• Several research and development units to support public and private sectors.
• Industrial Technology Assistance Program (iTAP) for SMEs
• National Innovation Agency
• Innovation coupon granted for approved projects to support 90% of RD expenses
incurred by innovation service provider (in cooperation with the Federation of Thai
Industries)
• Financial support of 25%-75% to be granted to prototype or pilot scale projects
• Interest free loan for up to 3 years to assist in the start-up of commercial operation
of innovation projects
FOR FURTHER
INFORMATION:
The Thailand Board of Investment (BOI): http://www.boi.go.th
The Food and Drug Administration: http://www.fda.moph.go.th/eng/index.stm
Thai Medical Device Technology Industry Association (THAIMED):
http://www.thaimed.co.th/index.php?page=aboutlang=en
16. CONTACT US
Head Offices
OFFICE OF THE BOARD OF INVESTMENT
555 Vibhavadi-Rangsit Rd., Chatuchak, Bangkok 10900
Tel: +66 (0) 2553-8111
Fax: +66 (0) 2553-8222
Website: www.boi.go.th
Email: head@boi.go.th
ONE START ONE STOP INVESTMENT CENTER (OSOS)
18th
Floor, Chamchuri Square Building,
319 Phayathai Rd., Pathumwan, Bangkok 10330
Tel: +66 (0) 2209-1100
Fax: +66 (0) 2209-1199
Website: osos.boi.go.th
Email: osos@boi.go.th
ONE STOP SERVICE CENTER FOR VISAS AND WORK PERMITS
18th
Floor, Chamchuri Square Building,
319 Phayathai Rd., Pathumwan, Bangkok 10330
Tel: +66 (0) 2209-1100
Fax: +66 (0) 2209-1194
Email: visawork@boi.go.th
INVESTOR CLUB ASSOCIATION (ICA)
12th
and 16th
Floor, TPT Building, 1 Soi Vibhavadi-Rangsit 19,
Vibhavadi-Rangsit Rd., Lad Yao, Chatuchak, Bangkok 10900
Tel: +66 (0) 2936-1429
Fax: +66 (0) 2936-1441-2
Website: www.ic.or.th
Email: is-investor@ic.or.th
Regional Offices
CHIANG MAI
Regional Investment and Economic Center 1
Airport Business Park 108-110,
90 Mahidol Road, Amphur Muang, Chiang Mai 50100
Tel: +66 (0) 5320 3397-400
Fax: +66 (0) 5320 3404
Email: chmai@boi.go.th
NAKHON RATCHASIMA
Regional Investment and Economic Center 2
2112/22 Mitraphab Road, Amphur Muang, Nakhon Ratchasima 30000
Tel: +66 (0) 4421 3184-6
Fax: +66 (0) 4421 3182
Email: korat@boi.go.th
KHONKAEN
Regional Investment and Economic Center 3
177/54 Moo 17, Mitraphab Road, Amphur Muang, Khonkaen 40000
Tel: +66 (0) 4327 1300-2
Fax: +66 (0) 4327 1303
Email: khonkaen@boi.go.th
CHONBURI
Regional Investment and Economic Center 4
46 Moo 5 Laem Chabang Industrial Estate, Sukhumvit Road,
Toongsukhla, Sriracha, Chonburi 20230
Tel: +66 (0) 3840 4900
Fax: +66 (0) 3840 4997, +66 (0) 3840 4999
Email: chonburi@boi.go.th
SONGKHLA
Regional Investment and Economic Center 5
7-15 Chaiyong Building Juti Uthit 1 Road, Hadd Yai, Songkhla 90110
Tel: +66 (0) 7434 7161-5
Fax: +66 (0) 7434 7160
Email: songkhla@boi.go.th
SURAT THANI
Regional Investment and Economic Center 6
49/21-22 Sriwichai Road, Makhamtia, Amphur Muang,
Surat Thani 84000
Tel: +66 (0) 7728 4637, +66 (0) 7728 4435
Fax: +66 (0) 7728 4638
Email: surat@boi.go.th
PHITSANULOK
Regional Investment and Economic Center 7
3rd
Floor, Thai Sivarat Building, 59/15 Boromtrilokkanat 2 Rd.,
Naimuang, Amphur Muang, Phitsanulok 65000
Tel: +66 (0) 5524-8111
Fax: +66 (0) 5524-8777
Email: phitsanulok@boi.go.th
Overseas Offices
BEIJING
Thailand Board of Investment, Beijing Office
Royal Thai Embassy, No.40 Guang Hua Rd., Beijing 100600 P.R.C.
Tel: +86-10-6532-4510
Fax: +86-10-6532-1620
Email: beijing@boi.go.th
FRANKFURT
Thailand Board of Investment, Frankfurt Office
Investment Section, Royal Thai Consulate-General
Bethmannstr. 58,5.0G
60311 Frankfurt am Main,
Federal Republic of Germany
Tel: +49 (069) 92 91 230
Fax: +49 (069) 92 91 2320
Email: fra@boi.go.th
GUANGZHOU
Thailand Board of Investment, Guangzhou Office
Investment Promotion Section, Royal Thai Consulate-General,
Room 1216-1218, Garden Tower, 368 Huanshi Dong Rd.,
Guangzhou 510064 P.R.C
Tel: +86-20-8333-8999 ext. 1216-8, +86-20-8387-7770
Fax: +86-20-8387-2700
Email: guangzhou@boi.go.th
LOS ANGELES
Thailand Board of Investment, Los Angeles Office
Royal Thai Consulate-General, 611 North Larchmont Boulevard,
3rd
Floor, Los Angeles CA 90004, U.S.A.
Tel: +1 (0)-323-960-1199
Fax: +1 (0)-323-960-1190
Email: boila@boi.go.th
MUMBAI
Thailand Board of Investment, Mumbai Office
Royal Thai Consulate-General
1st
Floor, Dalalmal House, Jamnalal Bajaj Marg,
Nariman Point, Mumbai - 400 021
Republic of India
Tel: +(91 22) 2204 1589-90
Fax: +(91 22) 2282 1071
Email: mumbai@boi.go.th
NEW YORK
Thailand Board of Investment, New York Office
7 World Trade Center, 34th
Floor. Suite F,
250 Greenwich Street, New York, New York 10007, U.S.A.
Tel: +1 (0) 212 422 9009
Fax: +1 (0) 212 422 9119
Email: nyc@boi.go.th
Website: www.thinkasiainvestthailand.com
OSAKA
Thailand Board of Investment, Osaka Office
Royal Thai Consulate-General, Bangkok Bank Building, 7th
Floor,
1-9-16 Kyutaro-Machi, Chuo-Ku, Osaka 541-0056 Japan
Tel: +81 (0) 6-6271-1395
Fax: +81 (0) 6-6271-1394
Email: osaka@boi.go.th
PARIS
Thailand Board of Investment, Paris Office
Ambassade Royale de Thaïlande
8, rue Greuze, 75116 Paris, France
Tel: +(33-1) 56 90 26 00
Fax: +(33-1) 56 90 26 02
Email: par@boi.go.th
SEOUL
Thailand Board of Investment, Seoul Office
#1804, 18th
Floor, Koryo Daeyeongak Center,
97 Toegye-ro, Jung-gu, Seoul, 100-706, Korea
Tel: +82-2-319-9998
Fax: +82-2-319-9997
Email: seoul@boi.go.th
SHANGHAI
Thailand Board of Investment, Shanghai Office
Royal Thai Consulate-General, 15th
Floor, Crystal Century Tower,
567 Weihai Rd., Shanghai 200041, P.R.C
Tel: +86-21-6288-9728-9
Fax: +86-21-6288-9730
Email: shanghai@boi.go.th
STOCKHOLM
Thailand Board of Investment, Stockholm Office
Stureplan 4C 4th
Floor, 114 35 Stockholm, Sweden
Tel: +46 (0) 8463 1158, +46 (0) 8463 1174-75
Fax: +46 (0) 8463 1160
Email: stockholm@boi.go.th
SYDNEY
Thailand Board of Investment, Sydney Office
Suite 101, Level 1, 234 George Street, Sydney,
New South Wales 2000, Australia
Tel: +61-2-9252-4884
Fax: +61-2-9252-2883
Email: sydney@boi.go.th
TAIPEI
Thailand Board of Investment, Taipei Office
Taipei World Trade Center, 3rd
Floor, Room 3E 39-40
No.5 Xin-Yi Rd., Sec. 5 Taipei 110, Taiwan R.O.C.
Tel: +886-2-2345-6663
Fax: +886-2-2345-9223
Email: taipei@boi.go.th
TOKYO
Thailand Board of Investment, Tokyo Office
Royal Thai Embassy, 8th
Floor, Fukuda Building West,
2-11-3, Akasaka, Minato-ku, Tokyo 107-0052 Japan
Tel: +81 (0) 3-3582-1806
Fax: +81 (0) 3-3589-5176
Email: tyo@boi.go.th